479 third-party lab reports published Volume pricing on every peptide, applied automatically in the cart: 3% off 2–3 · 8% off 4–5 · 12% off 6–7 · 15% off 8–9 · 20% off 10–19 · 25% off 20–29 · 30% off 30–39 · 35% off 40+ units · solvents and lab supplies excluded 99.65% median purity across 272 lots 257 / 257 lots pass sterility

‹ Certificates CJC No DAC IPA Blend Lot 1713

Lab report (Certificate of Analysis, COA)

CJC No DAC IPA Blend · 10mg/10mg (20mg Total)

Batch 1713 · tested July 12, 2026 (115 days ago) · released September 8, 2026

All tests passed

Batch
#1713 13 of 15 tests
Mass
10mg/10mg (20mg Total)
Purity
99.09%
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01

3 units tested for purity: 99.09 / 99.04 / 99.01% · spread 0.08 pt · net peptide content · cjc-1295 no dac 10.51 / 10.47 / 10.58 mg · net peptide content · ipamorelin 9.81 / 9.78 / 9.85 mg

Conformity: Units agree — every reported unit passed on all 11 test rows · purity spread 0.08 pt within the house limit · content spread (CJC-1295 no DAC) 1.0% within the house limit · content spread (Ipamorelin) 0.7% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-07-12

Vanguard · issuing lab

Verified by Vanguard Laboratory

This certificate is also hosted by Vanguard Laboratory — the issuing lab — on its own verification site.

View on VerifiedByVanguard.com
Laboratory ID V260629-8 004

Notes

Content audit 9 Sep 2026: size all sizes → #23469 10mg-each-20mg-total. Certificate prints: prints compound "CJC-1295 no DAC/Ipamorelin", lot "1713", lab id "V260629-8 004", content CJC-1295 no DAC: 10.51 / 10.47 / 10.58 m

Reports for this lot

  1. Vanguard Laboratory this report · tested July 12, 2026 · 11 results · QA approvalVanguard · issuing labAll tests passed

Test by test

11 results on the report · 4 rows computed from the per-unit values · 1 ISO 17025:2017-accredited lab · each test used up to 5 vials from this lot (rows are not added together) · every row names the chapter or house rule it follows

✓PurityWithin limits
avg 99.05% · 3 units · USP <621> (procedural chapter)
✓Purity consistency between unitsWithin house limit
3 units: 99.09 / 99.04 / 99.01% · spread 0.08 pt · house limit · caution past 0.50 pt, outside past 1.00 pt · per-unit USP <621> results
✓Net peptide content (assay) · CJC-1295 no DACWithin limits
avg 10.52 mg · 3 units · USP <621> (procedural chapter)
✓Net peptide content (assay) · IpamorelinWithin limits
avg 9.81 mg · 3 units · USP <621> (procedural chapter)
✓Content consistency between units · CJC-1295 no DACWithin house limit
3 units: 10.51 / 10.47 / 10.58 mg · spread 0.11 mg, 1.0% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
✓Content consistency between units · IpamorelinWithin house limit
3 units: 9.81 / 9.78 / 9.85 mg · spread 0.07 mg, 0.7% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
✓Heavy metalsWithin limits
5 elements non-detect · 2 units · dose-scaled limits derived from USP <232> (limits chapter)

✓Residual solventsWithin limits
all non-detect · 1 unit · USP <467> (procedural chapter)
✓Trifluoroacetic acidWithin limits
all non-detect · 1 unit · house limit · ion chromatography, the lab's method; no compendial chapter for the method run · limit <0.10% (the lab's)
✓EndotoxinsWithin limits
6.61 EU/mg · 3 units · USP <85> (procedural chapter)
✓Container closurePass
3 of 3 pass · 3 units · USP <1207> (informational chapter (1000-series))
✓SolubilityPass
3 of 3 pass · 3 units · house check · no compendial chapter
✓SterilityPass
5 of 5 pass · 5 units · USP <71> (procedural chapter)
✓Other · Adulterant screenWithin limits
all non-detect · 1 unit · no chapter named in the record; a screen
✓ConformityUnits agree
every reported unit passed on all 11 test rows · purity spread 0.08 pt within the house limit · content spread (CJC-1295 no DAC) 1.0% within the house limit · content spread (Ipamorelin) 0.7% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-07-12 · house check · agreement across all tests, unit to unit; QA approval corroborates

A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.

Tested by Vanguard Laboratory · Released September 8, 2026 · Verify: go.peptidology.co/1V1yRP

Permanent URL: https://peptidology.co/coa/cjc-no-dac-ipa-blend-lot-1713/

For research use only. Not intended for diagnostic or therapeutic use.

This certificate has been viewed 51 times.